Colorectal cancer: Histopathologic differences in tumor characteristics between patients with and without diabetes

Clinical Colorectal Cancer

Volumn 13, Issue 1, 2014, Pages 54-61

  Sharma, Anurag ^a   Ng, Hanyann ^b   Kumar, Abhishek ^a   Teli, Kunal ^a   Randhawa, Jeewanjot ^a   Record, James ^a,c   Maroules, Michael ^a,d  

^a ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

^b ST GEORGE S UNIVERSITY SCHOOL OF MEDICINE   (Grenada)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d SETON HALL UNIVERSITY   (United States)

Author keywords

Depth; Invasion; Lymphovascular; Signet ring; Staging

Indexed keywords

DEPTH; INVASION; LYMPHOVASCULAR; SIGNET-RING; STAGING;

AGED; COLORECTAL NEOPLASMS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84895075928     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2013.10.002     Document Type: Article

References (54)

1. Howlander N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute, Bethesda, MD. Available at: http://seer.cancer.gov/statfacts/html/colorect.html.
2. Colorectal Cancer Facts & Figures 2011-2013. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-028323.pdf.
3. F.A. Haggar, and R.P. Boushey Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors Clin Colon Rectal Surg 22 2009 191 197
4. E. Giovannucci Modifiable risk factors for colon cancer Gastroenterol Clin North Am 31 2002 925 943
5. S.C. Larsson, N. Orsini, and A. Wolk Diabetes mellitus and risk of colorectal cancer: a meta-analysis J Natl Cancer Inst 97 2005 1679 1687
6. R.R. Huxley, A. Ansary-Moghaddam, P. Clifton, S. Czernichow, C.L. Parr, and M. Woodward The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence Int J Cancer 125 2009 171 180
7. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Available at: http://www.cdc.gov/diabetes/pubs/factsheet11. htm.
8. E. Giovannucci, D.M. Harlan, and M.C. Archer et al. Diabetes and cancer: a consensus report Diabetes Care 33 2010 1674 1685
9. J.A. Meyerhardt, P.J. Catalano, and D.G. Haller et al. Impact of diabetes mellitus on outcomes in patients with colon cancer J Clin Oncol 21 2003 433 440
10. P. Vigneri, F. Frasca, and L. Sciacca et al. Diabetes and cancer Endocr Relat Cancer 16 2009 1103 1123
11. L.V. Van de Poll-Franse, H.R. Haak, and J.W.W. Coebergh et al. Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis Diabetologia 55 2012 2163 2172
12. A. Denley, J.M. Carroll, and G.V. Brierley et al. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors Mol Cell Biol 27 2007 3569 3577
13. E.J. Gallagher, and D. LeRoith Minireview: IGF, insulin, and cancer Endocrinology 152 2011 2546 2551
14. D.B. Ulanet, D.L. Ludwig, and C.R. Kahn et al. Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy Proc Natl Acad Sci U S A 107 2010 10791 10798
15. K. Masur, C. Vetter, and A. Hinz et al. Diabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation Br J Cancer 104 2011 345 352
16. S.L. Bowker, S.R. Majumdar, and P. Veugelers et al. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes Care 29 2006 254 258
17. E. Giovannucci Insulin, insulin-like growth factors and colon cancer: a review of the evidence J Nutr 131 2001 3109S 3120S
18. K. Mardilovich, S.L. Pankratz, and L.M. Shaw Expression and function of the insulin receptor substrate proteins in cancer Cell Commun Signal CCS 7 2009 14
19. D. LeRoith, and C.T. Roberts Jr. The insulin-like growth factor system and cancer Cancer Lett 195 2003 127 137
20. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
21. S.B. Edge, D.R. Byrd, and C.C. Compton et al. AJCC Cancer Staging Manual 7th ed 2009 Springer New York, NY
22. J.S. Han, K.H. Molberg, and V. Sarode Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases Breast J 17 2011 223 229
23. Jass JRSL International Histological Classification of Tumors: Histologic Typing of Intestinal Tumors 1989 World Health Organization Geneva, Switzerland 32 33
24. S.-B. Lim, C.S. Yu, S.J. Jang, T.W. Kim, J.H. Kim, and J.C. Kim Prognostic significance of lymphovascular invasion in sporadic colorectal cancer Dis Colon Rectum 53 2010 377 384
25. J.B. O'Connell, M.A. Maggard, and C.Y. Ko Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 2004 1420 1425
26. C.C. Compton, L.P. Fielding, and L.J. Burgart et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 124 2000 979 994
27. R.S. Bresalier, Y. Niv, and J.C. Byrd et al. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis J Clin Invest 87 1991 1037 1045
28. C.O. Sung, J.W. Seo, K.M. Kim, I.G. Do, S.W. Kim, and C.K. Park Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma Mod Pathol 21 2008 1533 1541
29. Y. Hamada, A. Oishi, and T. Shoji et al. Endocrine cells and prognosis in patients with colorectal carcinoma Cancer 69 1992 2641 2646
30. J.R. Hyngstrom, C.Y. Hu, and Y. Xing et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base Ann Surg Oncol 19 2012 2814 2821
31. S.Y. Tung, C.S. Wu, and P.C. Chen Primary signet ring cell carcinoma of colorectum: an age- and sex-matched controlled study Am J Gastroenterol 91 1996 2195 2199
32. H. Kang, J.B. O'Connell, and M.A. Maggard et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum Dis Colon Rectum 48 2005 1161 1168
33. J.W. Arends, T. Wiggers, and K. Verstijnen et al. The occurrence and clinicopathological significance of serotonin immunoreactive cells in large bowel carcinoma J Pathol 149 1986 97 102
34. S. Ogino, M. Brahmandam, and M. Cantor et al. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component Mod Pathol 19 2006 59 68
35. M.E. Börger, M.J. Gosens, and J.W. Jeuken et al. Signet ring cell differentiation in mucinous colorectal carcinoma J Pathol 212 2007 278 286
36. V.B. Astler, and F.A. Coller The prognostic significance of direct extension of carcinoma of the colon and rectum Ann Surg 139 1954 846 852
37. N.A. Shonka, J.R. Anderson, A.W. Panwalkar, E.C. Reed, P.D. Steen, and A.K. Ganti Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer Med Oncol 23 2006 515 519
38. J.M. Nagel, S. Bücker, and M. Wood et al. Less advanced stages of colon cancer in patients with type 2 diabetes mellitus: an unexpected finding? Exp Clin Endocrinol Diabetes 120 2012 224 228
39. G. Gatta, L. Ciccolallo, and R. Capocaccia et al. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology Eur J Cancer 39 2003 2214 2222
40. A. Caldarella, E. Crocetti, and L. Messerini et al. Trends in colorectal incidence by anatomic subsite from 1985 to 2005: a population-based study [e-pub] Int J Colorectal Dis 2013 doi:10.1007/s00384-013-1672-2
41. B. Iacopetta Are there two sides to colorectal cancer? Int J Cancer 101 2002 403 408
42. Y.-C. Huang, J.K. Lin, and W.S. Chen et al. Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease J Cancer Res Clin Oncol 137 2011 211 220
43. A.M. Nomura, G.N. Stemmermann, and P.H. Chyou Prospective study of serum cholesterol levels and large-bowel cancer J Natl Cancer Inst 83 1991 1403 1407
44. [No authors listed.] From the NIH: cholesterol and noncardiovascular mortality JAMA J Am Med Assoc 246 1981 731
45. R.R. Williams, P.D. Sorlie, M. Feinleib, P.M. McNamara, W.B. Kannel, and T.R. Dawber Cancer incidence by levels of cholesterol JAMA 245 1981 247 252
46. J.N. Poynter, S.B. Gruber, and P.D. Higgins et al. Statins and the risk of colorectal cancer N Engl J Med 352 2005 2184 2192
47. R.A. Hiatt, and B.H. Fireman Serum cholesterol and the incidence of cancer in a large cohort J Chronic Dis 39 1986 861 870
48. F. Cambien, P. Ducimetiere, and J. Richard Total serum cholesterol and cancer mortality in a middle-aged male population Am J Epidemiol 112 1980 388 394
49. Y. Yang, P.D. Mauldin, and M. Ebeling et al. Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients Cancer 119 2013 1512 1520
50. O. Giouleme, M.D. Diamantidis, and M.G. Katsaros Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms World J Gastroenterol 17 2011 444 448
51. S. Singh, H. Singh, and P.P. Singh et al. Anti-diabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis [e-pub] Cancer Epidemiol Biomarkers Prev 2013 doi:10.1158/1055-9965.EPI-13-0429
52. E.J. Gallagher, and D. Leroith Diabetes, antihyperglycemic medications and cancer risk: smoke or fire? Curr Opin Endocrinol Diabetes Obes 20 2013 485 494
53. B. Pasche Differential effects of aspirin before and after diagnosis of colorectal cancer JAMA 309 2013 2598 2599
54. M. Pollak Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 8 2008 915 928